Show bio +
Hide bio -
Joshua grew up in New Zealand, where he completed his PhD at the University of Otago. His PhD research combined bioinformatic analysis with molecular biology techniques to better understand the clinical significance and biological function of a protein commonly upregulated in metastatic breast cancer. After completing his PhD in 2021, Joshua joined the Dawson Lab in 2022 to begin his post-doctoral fellowship. Currently, Joshua is leading a research project which utilises next-generation sequencing to analyse circulating tumour DNA from the blood. His research is part of a larger clinical trial called PATINA, which comprises almost 500 HR+/HER2+ breast cancer patients, and aims to identify biomarkers that predict response to targeted therapy.